nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—AGTR1—dilated cardiomyopathy	0.552	1	CbGaD
Telmisartan—ABCC2—Spironolactone—dilated cardiomyopathy	0.133	0.42	CbGbCtD
Telmisartan—ABCC2—Furosemide—dilated cardiomyopathy	0.0909	0.287	CbGbCtD
Telmisartan—ABCB1—Lisinopril—dilated cardiomyopathy	0.0493	0.156	CbGbCtD
Telmisartan—ABCB1—Spironolactone—dilated cardiomyopathy	0.0434	0.137	CbGbCtD
Telmisartan—Anxiety depression—Lisinopril—dilated cardiomyopathy	0.0037	0.0401	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00344	0.105	CbGpPWpGaD
Telmisartan—AGTR1—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00268	0.0814	CbGpPWpGaD
Telmisartan—Azilsartan medoxomil—AGTR1—dilated cardiomyopathy	0.00254	0.45	CrCbGaD
Telmisartan—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00242	0.0262	CcSEcCtD
Telmisartan—Blood cholesterol increased—Furosemide—dilated cardiomyopathy	0.00201	0.0218	CcSEcCtD
Telmisartan—Diabetic—Lisinopril—dilated cardiomyopathy	0.00182	0.0197	CcSEcCtD
Telmisartan—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00146	0.0158	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00145	0.0439	CbGpPWpGaD
Telmisartan—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00137	0.0148	CcSEcCtD
Telmisartan—Drug eruption—Furosemide—dilated cardiomyopathy	0.00132	0.0143	CcSEcCtD
Telmisartan—Leg pain—Lisinopril—dilated cardiomyopathy	0.00132	0.0143	CcSEcCtD
Telmisartan—Bursitis—Lisinopril—dilated cardiomyopathy	0.00126	0.0136	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00123	0.0375	CbGpPWpGaD
Telmisartan—Olmesartan—AGTR1—dilated cardiomyopathy	0.00121	0.214	CrCbGaD
Telmisartan—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00117	0.0127	CcSEcCtD
Telmisartan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000974	0.0105	CcSEcCtD
Telmisartan—Gastritis—Spironolactone—dilated cardiomyopathy	0.000957	0.0104	CcSEcCtD
Telmisartan—Candesartan—AGTR1—dilated cardiomyopathy	0.000939	0.167	CrCbGaD
Telmisartan—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000925	0.01	CcSEcCtD
Telmisartan—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.000874	0.00946	CcSEcCtD
Telmisartan—Gout—Furosemide—dilated cardiomyopathy	0.000868	0.0094	CcSEcCtD
Telmisartan—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000861	0.00932	CcSEcCtD
Telmisartan—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000852	0.0259	CbGpPWpGaD
Telmisartan—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000851	0.00922	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000827	0.0252	CbGpPWpGaD
Telmisartan—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.000825	0.00893	CcSEcCtD
Telmisartan—Renal failure—Spironolactone—dilated cardiomyopathy	0.000819	0.00887	CcSEcCtD
Telmisartan—AGTR1—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000782	0.0238	CbGpPWpGaD
Telmisartan—Otitis media—Lisinopril—dilated cardiomyopathy	0.000781	0.00846	CcSEcCtD
Telmisartan—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000744	0.00806	CcSEcCtD
Telmisartan—Bladder pain—Furosemide—dilated cardiomyopathy	0.000733	0.00793	CcSEcCtD
Telmisartan—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000676	0.00732	CcSEcCtD
Telmisartan—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000669	0.00724	CcSEcCtD
Telmisartan—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000658	0.00712	CcSEcCtD
Telmisartan—Gout—Lisinopril—dilated cardiomyopathy	0.000651	0.00705	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000645	0.0196	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000632	0.0192	CbGpPWpGaD
Telmisartan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000626	0.00678	CcSEcCtD
Telmisartan—Purpura—Furosemide—dilated cardiomyopathy	0.00061	0.00661	CcSEcCtD
Telmisartan—Losartan—AGTR1—dilated cardiomyopathy	0.000605	0.107	CrCbGaD
Telmisartan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000604	0.00654	CcSEcCtD
Telmisartan—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000597	0.00647	CcSEcCtD
Telmisartan—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000594	0.00643	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.000592	0.018	CbGpPWpGaD
Telmisartan—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00059	0.00639	CcSEcCtD
Telmisartan—Malaise—Spironolactone—dilated cardiomyopathy	0.000587	0.00636	CcSEcCtD
Telmisartan—Cystitis—Lisinopril—dilated cardiomyopathy	0.000587	0.00636	CcSEcCtD
Telmisartan—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000551	0.00597	CcSEcCtD
Telmisartan—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00055	0.00595	CcSEcCtD
Telmisartan—Discomfort—Spironolactone—dilated cardiomyopathy	0.000548	0.00593	CcSEcCtD
Telmisartan—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000537	0.00582	CcSEcCtD
Telmisartan—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000535	0.0058	CcSEcCtD
Telmisartan—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000533	0.00577	CcSEcCtD
Telmisartan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000531	0.00575	CcSEcCtD
Telmisartan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00053	0.00574	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000526	0.016	CbGpPWpGaD
Telmisartan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00052	0.00563	CcSEcCtD
Telmisartan—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000519	0.00562	CcSEcCtD
Telmisartan—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000512	0.00554	CcSEcCtD
Telmisartan—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000507	0.00549	CcSEcCtD
Telmisartan—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000505	0.00547	CcSEcCtD
Telmisartan—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000503	0.00545	CcSEcCtD
Telmisartan—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000498	0.00539	CcSEcCtD
Telmisartan—Eczema—Lisinopril—dilated cardiomyopathy	0.000491	0.00532	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00048	0.0146	CbGpPWpGaD
Telmisartan—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000478	0.00518	CcSEcCtD
Telmisartan—Somnolence—Spironolactone—dilated cardiomyopathy	0.000472	0.00512	CcSEcCtD
Telmisartan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00047	0.00509	CcSEcCtD
Telmisartan—AGTR1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.000467	0.0142	CbGpPWpGaD
Telmisartan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000466	0.00504	CcSEcCtD
Telmisartan—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000464	0.00502	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000459	0.00497	CcSEcCtD
Telmisartan—Arthritis—Lisinopril—dilated cardiomyopathy	0.000454	0.00492	CcSEcCtD
Telmisartan—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000452	0.0049	CcSEcCtD
Telmisartan—AGTR1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000451	0.0137	CbGpPWpGaD
Telmisartan—Renal failure—Furosemide—dilated cardiomyopathy	0.000446	0.00482	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000446	0.0135	CbGpPWpGaD
Telmisartan—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000441	0.00478	CcSEcCtD
Telmisartan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000441	0.00478	CcSEcCtD
Telmisartan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000438	0.00474	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000435	0.0132	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.00043	0.0131	CbGpPWpGaD
Telmisartan—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000429	0.00464	CcSEcCtD
Telmisartan—Face oedema—Lisinopril—dilated cardiomyopathy	0.000426	0.00461	CcSEcCtD
Telmisartan—Urticaria—Spironolactone—dilated cardiomyopathy	0.000422	0.00457	CcSEcCtD
Telmisartan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00042	0.00455	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000414	0.0126	CbGpPWpGaD
Telmisartan—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000413	0.00448	CcSEcCtD
Telmisartan—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000403	0.00436	CcSEcCtD
Telmisartan—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000402	0.00435	CcSEcCtD
Telmisartan—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000401	0.0122	CbGpPWpGaD
Telmisartan—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000399	0.00432	CcSEcCtD
Telmisartan—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000399	0.00432	CcSEcCtD
Telmisartan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000397	0.0043	CcSEcCtD
Telmisartan—Visual impairment—Furosemide—dilated cardiomyopathy	0.000392	0.00425	CcSEcCtD
Telmisartan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000392	0.00424	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000391	0.0119	CbGpPWpGaD
Telmisartan—Gastritis—Lisinopril—dilated cardiomyopathy	0.000391	0.00423	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.000382	0.0116	CbGpPWpGaD
Telmisartan—Asthma—Lisinopril—dilated cardiomyopathy	0.000381	0.00413	CcSEcCtD
Telmisartan—Eye disorder—Furosemide—dilated cardiomyopathy	0.00038	0.00412	CcSEcCtD
Telmisartan—Tinnitus—Furosemide—dilated cardiomyopathy	0.000379	0.00411	CcSEcCtD
Telmisartan—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000378	0.00409	CcSEcCtD
Telmisartan—Pruritus—Spironolactone—dilated cardiomyopathy	0.000376	0.00407	CcSEcCtD
Telmisartan—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000375	0.00406	CcSEcCtD
Telmisartan—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000372	0.00402	CcSEcCtD
Telmisartan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000372	0.00402	CcSEcCtD
Telmisartan—Angiopathy—Furosemide—dilated cardiomyopathy	0.000369	0.004	CcSEcCtD
Telmisartan—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000368	0.00398	CcSEcCtD
Telmisartan—PPARG—Noncanonical Wnt signaling pathway—RAC1—dilated cardiomyopathy	0.000367	0.0112	CbGpPWpGaD
Telmisartan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000367	0.00397	CcSEcCtD
Telmisartan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000364	0.00394	CcSEcCtD
Telmisartan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000364	0.00394	CcSEcCtD
Telmisartan—Dysuria—Lisinopril—dilated cardiomyopathy	0.000357	0.00386	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000355	0.00384	CcSEcCtD
Telmisartan—Erythema—Furosemide—dilated cardiomyopathy	0.000354	0.00384	CcSEcCtD
Telmisartan—Malnutrition—Furosemide—dilated cardiomyopathy	0.000354	0.00384	CcSEcCtD
Telmisartan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000351	0.0038	CcSEcCtD
Telmisartan—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000351	0.0038	CcSEcCtD
Telmisartan—Losartan—ACE—dilated cardiomyopathy	0.00035	0.062	CrCbGaD
Telmisartan—Flatulence—Furosemide—dilated cardiomyopathy	0.000349	0.00378	CcSEcCtD
Telmisartan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000347	0.00376	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.000345	0.0105	CbGpPWpGaD
Telmisartan—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000342	0.0037	CcSEcCtD
Telmisartan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000341	0.00369	CcSEcCtD
Telmisartan—Depression—Lisinopril—dilated cardiomyopathy	0.000339	0.00367	CcSEcCtD
Telmisartan—Vomiting—Spironolactone—dilated cardiomyopathy	0.000338	0.00366	CcSEcCtD
Telmisartan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000335	0.00363	CcSEcCtD
Telmisartan—Rash—Spironolactone—dilated cardiomyopathy	0.000335	0.00363	CcSEcCtD
Telmisartan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000335	0.00362	CcSEcCtD
Telmisartan—Renal failure—Lisinopril—dilated cardiomyopathy	0.000334	0.00362	CcSEcCtD
Telmisartan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000333	0.00361	CcSEcCtD
Telmisartan—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000333	0.00361	CcSEcCtD
Telmisartan—Headache—Spironolactone—dilated cardiomyopathy	0.000333	0.0036	CcSEcCtD
Telmisartan—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000331	0.00358	CcSEcCtD
Telmisartan—Anaemia—Furosemide—dilated cardiomyopathy	0.000327	0.00355	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—GJA1—dilated cardiomyopathy	0.000327	0.00994	CbGpPWpGaD
Telmisartan—Haematuria—Lisinopril—dilated cardiomyopathy	0.000324	0.00351	CcSEcCtD
Telmisartan—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000322	0.00348	CcSEcCtD
Telmisartan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000321	0.00347	CcSEcCtD
Telmisartan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000319	0.00345	CcSEcCtD
Telmisartan—Vertigo—Furosemide—dilated cardiomyopathy	0.000318	0.00345	CcSEcCtD
Telmisartan—Nausea—Spironolactone—dilated cardiomyopathy	0.000316	0.00342	CcSEcCtD
Telmisartan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000311	0.00337	CcSEcCtD
Telmisartan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000306	0.00331	CcSEcCtD
Telmisartan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000303	0.00328	CcSEcCtD
Telmisartan—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000302	0.00326	CcSEcCtD
Telmisartan—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000301	0.00326	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0003	0.00324	CcSEcCtD
Telmisartan—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000299	0.00324	CcSEcCtD
Telmisartan—Dry mouth—Furosemide—dilated cardiomyopathy	0.000295	0.00319	CcSEcCtD
Telmisartan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000289	0.00313	CcSEcCtD
Telmisartan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000285	0.00308	CcSEcCtD
Telmisartan—Shock—Furosemide—dilated cardiomyopathy	0.000284	0.00308	CcSEcCtD
Telmisartan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000284	0.00307	CcSEcCtD
Telmisartan—Flushing—Lisinopril—dilated cardiomyopathy	0.000283	0.00307	CcSEcCtD
Telmisartan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000283	0.00306	CcSEcCtD
Telmisartan—Skin disorder—Furosemide—dilated cardiomyopathy	0.000281	0.00304	CcSEcCtD
Telmisartan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000279	0.00303	CcSEcCtD
Telmisartan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000277	0.003	CcSEcCtD
Telmisartan—Anorexia—Furosemide—dilated cardiomyopathy	0.000276	0.00298	CcSEcCtD
Telmisartan—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000275	0.00298	CcSEcCtD
Telmisartan—Chills—Lisinopril—dilated cardiomyopathy	0.000274	0.00297	CcSEcCtD
Telmisartan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000273	0.00295	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000272	0.00828	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000272	0.00827	CbGpPWpGaD
Telmisartan—Hypotension—Furosemide—dilated cardiomyopathy	0.00027	0.00293	CcSEcCtD
Telmisartan—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000267	0.0029	CcSEcCtD
Telmisartan—Erythema—Lisinopril—dilated cardiomyopathy	0.000266	0.00288	CcSEcCtD
Telmisartan—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000266	0.00288	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000263	0.00801	CbGpPWpGaD
Telmisartan—Flatulence—Lisinopril—dilated cardiomyopathy	0.000262	0.00284	CcSEcCtD
Telmisartan—Tension—Lisinopril—dilated cardiomyopathy	0.000261	0.00282	CcSEcCtD
Telmisartan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00026	0.00282	CcSEcCtD
Telmisartan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00026	0.00281	CcSEcCtD
Telmisartan—Nervousness—Lisinopril—dilated cardiomyopathy	0.000258	0.0028	CcSEcCtD
Telmisartan—Back pain—Lisinopril—dilated cardiomyopathy	0.000257	0.00278	CcSEcCtD
Telmisartan—Somnolence—Furosemide—dilated cardiomyopathy	0.000257	0.00278	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000256	0.00779	CbGpPWpGaD
Telmisartan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000256	0.00277	CcSEcCtD
Telmisartan—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000255	0.00776	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000253	0.0077	CbGpPWpGaD
Telmisartan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000251	0.00272	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00025	0.0027	CcSEcCtD
Telmisartan—Fatigue—Furosemide—dilated cardiomyopathy	0.000249	0.0027	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—RAC1—dilated cardiomyopathy	0.000249	0.00757	CbGpPWpGaD
Telmisartan—Constipation—Furosemide—dilated cardiomyopathy	0.000247	0.00268	CcSEcCtD
Telmisartan—Pain—Furosemide—dilated cardiomyopathy	0.000247	0.00268	CcSEcCtD
Telmisartan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000247	0.00267	CcSEcCtD
Telmisartan—Anaemia—Lisinopril—dilated cardiomyopathy	0.000246	0.00266	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000244	0.00743	CbGpPWpGaD
Telmisartan—Angioedema—Lisinopril—dilated cardiomyopathy	0.000243	0.00263	CcSEcCtD
Telmisartan—Malaise—Lisinopril—dilated cardiomyopathy	0.00024	0.0026	CcSEcCtD
Telmisartan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000239	0.00259	CcSEcCtD
Telmisartan—Syncope—Lisinopril—dilated cardiomyopathy	0.000238	0.00258	CcSEcCtD
Telmisartan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000238	0.00258	CcSEcCtD
Telmisartan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000236	0.00256	CcSEcCtD
Telmisartan—Palpitations—Lisinopril—dilated cardiomyopathy	0.000235	0.00254	CcSEcCtD
Telmisartan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000234	0.00253	CcSEcCtD
Telmisartan—Cough—Lisinopril—dilated cardiomyopathy	0.000232	0.00251	CcSEcCtD
Telmisartan—Urticaria—Furosemide—dilated cardiomyopathy	0.00023	0.00249	CcSEcCtD
Telmisartan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000229	0.00247	CcSEcCtD
Telmisartan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000229	0.00247	CcSEcCtD
Telmisartan—Myalgia—Lisinopril—dilated cardiomyopathy	0.000226	0.00245	CcSEcCtD
Telmisartan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000226	0.00245	CcSEcCtD
Telmisartan—Chest pain—Lisinopril—dilated cardiomyopathy	0.000226	0.00245	CcSEcCtD
Telmisartan—Anxiety—Lisinopril—dilated cardiomyopathy	0.000226	0.00244	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000225	0.00243	CcSEcCtD
Telmisartan—Discomfort—Lisinopril—dilated cardiomyopathy	0.000224	0.00242	CcSEcCtD
Telmisartan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000221	0.0024	CcSEcCtD
Telmisartan—Oedema—Lisinopril—dilated cardiomyopathy	0.000217	0.00235	CcSEcCtD
Telmisartan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000217	0.00235	CcSEcCtD
Telmisartan—Infection—Lisinopril—dilated cardiomyopathy	0.000216	0.00233	CcSEcCtD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.000215	0.00653	CbGpPWpGaD
Telmisartan—Shock—Lisinopril—dilated cardiomyopathy	0.000213	0.00231	CcSEcCtD
Telmisartan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000213	0.00231	CcSEcCtD
Telmisartan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000212	0.0023	CcSEcCtD
Telmisartan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000212	0.00229	CcSEcCtD
Telmisartan—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000211	0.00228	CcSEcCtD
Telmisartan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00021	0.00227	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00021	0.00637	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00021	0.00637	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—LMNA—dilated cardiomyopathy	0.000209	0.00635	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000209	0.00635	CbGpPWpGaD
Telmisartan—Asthenia—Furosemide—dilated cardiomyopathy	0.000207	0.00225	CcSEcCtD
Telmisartan—Anorexia—Lisinopril—dilated cardiomyopathy	0.000207	0.00224	CcSEcCtD
Telmisartan—Pruritus—Furosemide—dilated cardiomyopathy	0.000205	0.00221	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000203	0.00618	CbGpPWpGaD
Telmisartan—Hypotension—Lisinopril—dilated cardiomyopathy	0.000203	0.00219	CcSEcCtD
Telmisartan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000198	0.00214	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000198	0.00214	CcSEcCtD
Telmisartan—Insomnia—Lisinopril—dilated cardiomyopathy	0.000196	0.00212	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000195	0.00592	CbGpPWpGaD
Telmisartan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000195	0.00211	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000194	0.0059	CbGpPWpGaD
Telmisartan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000193	0.00209	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.000193	0.00587	CbGpPWpGaD
Telmisartan—Somnolence—Lisinopril—dilated cardiomyopathy	0.000193	0.00209	CcSEcCtD
Telmisartan—Dizziness—Furosemide—dilated cardiomyopathy	0.000191	0.00207	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000191	0.00581	CbGpPWpGaD
Telmisartan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000191	0.00207	CcSEcCtD
Telmisartan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000189	0.00204	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000188	0.00571	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000187	0.00203	CcSEcCtD
Telmisartan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000187	0.00202	CcSEcCtD
Telmisartan—Pain—Lisinopril—dilated cardiomyopathy	0.000185	0.00201	CcSEcCtD
Telmisartan—Constipation—Lisinopril—dilated cardiomyopathy	0.000185	0.00201	CcSEcCtD
Telmisartan—Vomiting—Furosemide—dilated cardiomyopathy	0.000184	0.00199	CcSEcCtD
Telmisartan—Rash—Furosemide—dilated cardiomyopathy	0.000182	0.00197	CcSEcCtD
Telmisartan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000182	0.00197	CcSEcCtD
Telmisartan—Headache—Furosemide—dilated cardiomyopathy	0.000181	0.00196	CcSEcCtD
Telmisartan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000179	0.00194	CcSEcCtD
Telmisartan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000177	0.00192	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000173	0.00527	CbGpPWpGaD
Telmisartan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000172	0.00187	CcSEcCtD
Telmisartan—Nausea—Furosemide—dilated cardiomyopathy	0.000172	0.00186	CcSEcCtD
Telmisartan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000171	0.00186	CcSEcCtD
Telmisartan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000171	0.00186	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000164	0.00499	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000163	0.00495	CbGpPWpGaD
Telmisartan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00016	0.00173	CcSEcCtD
Telmisartan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000156	0.00169	CcSEcCtD
Telmisartan—Pruritus—Lisinopril—dilated cardiomyopathy	0.000153	0.00166	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000153	0.00464	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.00015	0.00455	CbGpPWpGaD
Telmisartan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000148	0.00161	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000148	0.00449	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000145	0.00441	CbGpPWpGaD
Telmisartan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000143	0.00155	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000143	0.00434	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000142	0.00432	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000141	0.00427	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000141	0.00427	CbGpPWpGaD
Telmisartan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000138	0.00149	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000138	0.00418	CbGpPWpGaD
Telmisartan—Rash—Lisinopril—dilated cardiomyopathy	0.000137	0.00148	CcSEcCtD
Telmisartan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000137	0.00148	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—RAF1—dilated cardiomyopathy	0.000136	0.00415	CbGpPWpGaD
Telmisartan—Headache—Lisinopril—dilated cardiomyopathy	0.000136	0.00147	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000134	0.00407	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000134	0.00407	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000131	0.00397	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000131	0.00397	CbGpPWpGaD
Telmisartan—Nausea—Lisinopril—dilated cardiomyopathy	0.000129	0.0014	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000128	0.00389	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000127	0.00385	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000124	0.00378	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—FAS—dilated cardiomyopathy	0.000122	0.00371	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00012	0.00364	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000115	0.00349	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—AGT—dilated cardiomyopathy	0.000114	0.00348	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000113	0.00345	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000113	0.00345	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000113	0.00344	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000111	0.00338	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000107	0.00325	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000107	0.00325	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000104	0.00315	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000103	0.00312	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000103	0.00312	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	9.95e-05	0.00303	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.84e-05	0.00299	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	9.79e-05	0.00298	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	9.64e-05	0.00293	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.58e-05	0.00291	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.58e-05	0.00291	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	9.54e-05	0.0029	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	9.05e-05	0.00275	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	8.97e-05	0.00273	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.9e-05	0.00271	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	8.81e-05	0.00268	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—FAS—dilated cardiomyopathy	8.61e-05	0.00262	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.56e-05	0.0026	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	8.5e-05	0.00259	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	8.5e-05	0.00259	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.33e-05	0.00253	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.33e-05	0.00253	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—PSEN2—dilated cardiomyopathy	8.18e-05	0.00249	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	8e-05	0.00243	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	7.88e-05	0.0024	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	7.81e-05	0.00237	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.74e-05	0.00235	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ANKRD1—dilated cardiomyopathy	7.72e-05	0.00235	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	7.69e-05	0.00234	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	7.61e-05	0.00231	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	7.43e-05	0.00226	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TAZ—dilated cardiomyopathy	7.26e-05	0.00221	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	7.17e-05	0.00218	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	7.13e-05	0.00217	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7e-05	0.00213	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR3C2—dilated cardiomyopathy	6.88e-05	0.00209	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.58e-05	0.002	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SDHA—dilated cardiomyopathy	6.56e-05	0.002	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.05e-05	0.00184	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.05e-05	0.00184	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	5.79e-05	0.00176	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	5.63e-05	0.00171	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.62e-05	0.00171	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.49e-05	0.00167	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.49e-05	0.00167	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.45e-05	0.00166	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	5.29e-05	0.00161	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	5.18e-05	0.00158	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	5.12e-05	0.00156	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.11e-05	0.00155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.95e-05	0.0015	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	4.89e-05	0.00149	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	4.78e-05	0.00145	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.69e-05	0.00143	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.63e-05	0.00141	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.57e-05	0.00139	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.5e-05	0.00137	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.5e-05	0.00137	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.41e-05	0.00134	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	4.37e-05	0.00133	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	4.32e-05	0.00131	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.19e-05	0.00127	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.11e-05	0.00125	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	4.11e-05	0.00125	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.01e-05	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4e-05	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.9e-05	0.00119	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.67e-05	0.00112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.65e-05	0.00111	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.54e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.51e-05	0.00107	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.47e-05	0.00105	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.43e-05	0.00104	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.27e-05	0.000995	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.24e-05	0.000987	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.24e-05	0.000987	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.12e-05	0.000948	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.11e-05	0.000946	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.04e-05	0.000925	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.04e-05	0.000925	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.02e-05	0.000917	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.97e-05	0.000904	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.93e-05	0.000891	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.92e-05	0.000888	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.86e-05	0.00087	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	2.73e-05	0.000829	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.71e-05	0.000825	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.65e-05	0.000806	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.59e-05	0.000787	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.37e-05	0.00072	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.3e-05	0.000699	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	2.09e-05	0.000635	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.06e-05	0.000627	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	2.03e-05	0.000619	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.03e-05	0.000618	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.94e-05	0.00059	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	1.87e-05	0.000569	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.84e-05	0.000559	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.83e-05	0.000557	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX1—dilated cardiomyopathy	1.78e-05	0.000542	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	1.78e-05	0.000542	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.76e-05	0.000534	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CD36—dilated cardiomyopathy	1.74e-05	0.000528	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.000513	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.62e-05	0.000492	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.58e-05	0.000479	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.57e-05	0.000479	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGT—dilated cardiomyopathy	1.56e-05	0.000475	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.5e-05	0.000457	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.42e-05	0.000431	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.41e-05	0.00043	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	0.000395	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000385	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.22e-05	0.00037	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	0.000347	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.13e-06	0.000278	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.36e-06	0.000254	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	7.2e-06	0.000219	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.03e-06	0.000214	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	7.01e-06	0.000213	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	6.84e-06	0.000208	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	6.31e-06	0.000192	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.16e-06	0.000187	CbGpPWpGaD
